Human papillomavirus-positive well-differentiated villoglandular adenocarcinoma of the uterine cervix: A case report and review of the literature

Gynecol Oncol. 2000 Jun;77(3):473-7. doi: 10.1006/gyno.2000.5804.

Abstract

Objective: A case of well-differentiated villoglandular adenocarcinoma of the uterine cervix, which was positive for human papillomavirus type 18, was reported.

Methods: The patient was a 52-year-old multipara who was referred to our department because of an abnormal Papanicolaou smear. A 4.0-cm exophytic lesion involving the cervix was detected. She was staged as FIGO IIa and radical hysterectomy combined with bilateral pelvic lymphadenectomy was performed. In addition to histopathological examination of the resected tumor, immunohistochemical studies of estrogen and progesterone receptors were performed using monoclonal antibodies. Detection of human papillomavirus DNA was attempted by polymerase chain reaction using consensus primers.

Results: The tumor was a typical well-differentiated villoglandular adenocarcinoma involving the vaginal wall. Both estrogen and progesterone receptors were negative. Human papillomavirus type 18 DNA was detected in the resected tumor.

Conclusion: 'This is the first report of a case of typical well-differentiated villoglandular adenocarcinoma which was positive for human papillomavirus.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / virology*
  • DNA, Viral / analysis
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Papillomaviridae / genetics
  • Papillomaviridae / isolation & purification*
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / genetics
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Tumor Virus Infections / complications*
  • Tumor Virus Infections / genetics
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / virology*

Substances

  • DNA, Viral
  • Receptors, Estrogen
  • Receptors, Progesterone